Health
Research into COVID treatments catching up – Esperance Express
Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 deaths and…
Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 deaths and hospitalisations.
Molnupiravir is still being trialled in the US and is yet to gain regulatory authorisation.
But the federal government…
Continue Reading
-
Noosa News22 hours agoChild sex offenders to be known in Queensland public registry
-
General22 hours agoThousands flood cities demanding action on Palestine
-
General21 hours agoNRLW Sunday: Brisbane Broncos hammer Newcastle Knights, Cronulla Sharks move to third on ladder
-
General13 hours agoFirst home buyers score early access to deposit scheme